Gå til indhold
You are here: Home Research and Innovation COVID.-19 research Danish research and innovation initiatives related to COVID-19 Clinical trials and data regulatory approval of Covid-19-related research projects

Clinical trials and data regulatory approval of Covid-19-related research projects

The authorities responsible for data protection and the approval of data use are urgently considering the sharing of data from research into COVID-19, and the approval of research projects about COVID-19.

The Danish Ministry of Health has ensured that the authorities within its remit responsible for data protection and the approval of data use are ready to fast track the dissemination of data for use in COVID-19 research and to urgently approve research projects on COVID-19. This applies to approval procedures within the Danish Medicines Agency, the Danish Health Data Authority and the Danish Patient Safety Authority.

 The Minister of Health in collaboration with the Minister of Higher Education and Science has requested the regional council chairmen to ensure the accelerated approval by regional approval bodies of applications for the approval of research projects and the dissemination of relevant health data.

For further information on regulatory approvals and the Scientific Ethics Committee system: 

Clinical trials and data regulatory approval

last modified Jun 19, 2020